Patents by Inventor Andrew Heaton

Andrew Heaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR MOVING A YAW DRIVE IN A WIND TURBINE
    Publication number: 20250027476
    Abstract: A method, a moving device and a system for moving a yaw drive in a wind turbine is provided.
    Type: Application
    Filed: July 11, 2024
    Publication date: January 23, 2025
    Inventor: Andrew Heaton
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20230372287
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 23, 2023
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20230145478
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: January 13, 2023
    Publication date: May 11, 2023
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 11583514
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: February 21, 2023
    Assignee: MEI Pharma, Inc.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20210000790
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: September 17, 2020
    Publication date: January 7, 2021
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Functionalised benzopyran compounds and use thereof
    Patent number: 10370349
    Abstract: Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer can be one or more of pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites or peritoneal cancer.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: August 6, 2019
    Assignee: Kazia Therapeutics Limited
    Inventors: Andrew Heaton, David Brown, Graham Kelly
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20190142790
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: September 12, 2018
    Publication date: May 16, 2019
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 10105346
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: October 23, 2018
    Assignee: MEI PHARMA, INC.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • FUNCTIONALISED BENZOPYRAN COMPOUNDS AND USE THEREOF
    Publication number: 20180141925
    Abstract: Benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence. The cancer can be one or more of pancreatic cancer, colorectal cancer, melanoma, prostate cancer, brain cancer (including paediatric and adult), ovarian cancer, breast cancer, lung cancer, liver cancer, uterine cancer, neuroblastoma, mesothelioma, malignant ascites or peritoneal cancer.
    Type: Application
    Filed: June 5, 2017
    Publication date: May 24, 2018
    Inventors: Andrew Heaton, David Brown, Graham Kelly
  • ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20170246142
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Application
    Filed: March 10, 2017
    Publication date: August 31, 2017
    Inventors: George JEOFFREYS, Alison JOHNSON, Andrew HEATON, Ofir MORENO
  • Functionalised benzopyran compounds and use thereof
    Patent number: 9701655
    Abstract: The present invention relates broadly to anti-cancer agents. In particular, the present invention relates to selected benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: July 11, 2017
    Assignee: NOVOGEN LIMITED
    Inventors: Andrew Heaton, David Brown, Graham Kelly
  • FUNCTIONALISED AND SUBSTITUTED CARBAZOLES AS ANTI-CANCER AGENTS
    Publication number: 20170158636
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 8, 2017
    Inventors: Ian James, Ian Dixon, Andrew Heaton, Eleanor Eiffe, Peter Gunning
  • FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS
    Publication number: 20170152226
    Abstract: The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.
    Type: Application
    Filed: July 16, 2015
    Publication date: June 1, 2017
    Inventors: Andrew Heaton, Eleanor Eiffe, Narender Pottabathini, Peter Gunning
  • Isoflavonoid compounds and methods for the treatment of cancer
    Patent number: 9663484
    Abstract: Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.
    Type: Grant
    Filed: November 1, 2011
    Date of Patent: May 30, 2017
    Assignee: MEI PHARMA, INC.
    Inventors: George Jeoffreys, Alison Johnson, Andrew Heaton, Ofir Moreno
  • FUNCTIONALISED BENZOPYRAN COMPOUNDS AND USE THEREOF
    Publication number: 20160340329
    Abstract: The present invention relates broadly to anti-cancer agents. In particular, the present invention relates to selected benzopyran compounds, the preparation thereof, and their use in methods for treating cancer and reducing the incidence or risk of cancer recurrence.
    Type: Application
    Filed: February 5, 2015
    Publication date: November 24, 2016
    Inventors: Andrew Heaton, David Brown, Graham Kelly
  • SUBSTITUTED CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY
    Publication number: 20160287555
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: June 7, 2016
    Publication date: October 6, 2016
    Inventors: Andrew Heaton, Alan James Husband
  • Substituted chroman derivatives, medicaments and use in therapy
    Patent number: 9381186
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: July 5, 2016
    Assignee: MEI PHARMA, INC.
    Inventors: Andrew Heaton, Alan James Husband
  • CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY
    Publication number: 20160136129
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: October 26, 2015
    Publication date: May 19, 2016
    Inventors: Andrew Heaton, Alan Husband
  • SUBSTITUTED CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY
    Publication number: 20150352074
    Abstract: Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Application
    Filed: August 18, 2015
    Publication date: December 10, 2015
    Inventors: Andrew Heaton, Alan James Husband
  • Chroman derivatives, medicaments and use in therapy
    Patent number: 9198895
    Abstract: Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
    Type: Grant
    Filed: January 5, 2015
    Date of Patent: December 1, 2015
    Assignee: MEI Pharma, Inc.
    Inventors: Andrew Heaton, Alan Husband